Philips and Traxtal to develop image-guided therapy solutions using
22 May 2007
Andover, Mass. Royal Philips Electronics (NYSE: PHG; AEX:
PHI) and Canadian company Traxtal Inc. will collaborate to develop
integrated soft tissue therapeutic and diagnostic navigation solutions.
Combining Philips’ diagnostic and interventional imaging with Traxtal’s
surgical navigation and therapy systems, the companies will offer a broad
spectrum of integrated imaging and navigation solutions. Philips also owns a
minority stake in Traxtal.
Leveraging Philips’ technology innovations in
the fields of image processing and modeling, and the advanced navigation
solutions provided by Traxtal’s PercuNav system, the companies aim to create
the most advanced soft-tissue navigation systems on the market.
Philips and Traxtal researchers are working with multiple modalities,
including ultrasound, computed tomography (CT) and magnetic resonance (MR),
to develop a technology offering that has the potential to improve patient
outcomes and treatment accuracy through improved visualization, as well as
to realize possible cost savings as procedures can be done more efficiently.
“We are delighted to be working with Philips, one of the world’s leading
medical imaging companies, as we bring this exciting technology to the
marketplace,” said Dr. Neil Glossop, president of Traxtal. “We share a
common commitment to excellence in patient care and empowerment of
physicians through technology.”
The Traxtal PercuNav system provides
advanced navigation solutions for interventional radiologists performing
image-guided percutaneous diagnostic and therapeutic procedures, such as
biopsies and radio-frequency ablations. PercuNav helps physicians guide
minimally invasive devices such as needles and probes into the body using
electromagnetic tracking technology. The system provides physicians with a
simple, intuitive three-dimensional visualization showing the tool position
superimposed on the patient’s medical images. PercuNav also provides
multimodality image fusion for combining ultrasound, CT and MR images in
real-time during the interventional procedure.
“This cooperation will
further strengthen Philips’ position as a leading provider of minimal
invasive therapy solutions,” said Diego Olego, CTO of Philips Medical
Systems. “Our combined expertise will create a unique opportunity for
Philips to become the imaging supplier of choice in the image guided therapy
market and it lays the foundation for development of new treatments and
therapies, including solutions that may help provide better clinical
outcomes, with less risk to the patient, at a lower cost.”